Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.31 | N/A |
| PEG Ratio (TTM) | 1.09 | N/A |
| P/S Ratio (TTM) | 0.19 | N/A |
| P/B Ratio (TTM) | 1.16 | N/A |
| P/FCF Ratio (TTM) | 124.88 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.25 | N/A |
| Price to 5YR AVG FCF Ratio | 7.22 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.72% | N/A |
| ROE (TTM) | 11.42% | N/A |
| Net Profit Margin (TTM) | 1.90% | N/A |
| ROIC 5YR AVG | 10.81% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 587.46% | 3.45% | 27.72% |
| Revenue | 2.55% | 28.80% | 21.54% |
| Net Income | 588.70% | 19.38% | 34.44% |
| Cash Flow | 10.78% | 89.22% | 69.04% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.10 | N/A |
| Quick Ratio (TTM) | 1.10 | N/A |
| D/E Ratio (TTM) | 0.64 | N/A |
| Interest Coverage (TTM) | 3.94 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.79 | N/A |
| LTL to 5YR AVG FCF | 4.39 | N/A |
| Shares Outstanding Growth 5YR AVG | 7.85% | N/A |